53
Views
41
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics Following a Loading Plus a Continuous Infusion of Pralidoxime Compared with the Traditional Short Infusion Regimen in Human Volunteers

, , , &
Pages 289-295 | Published online: 25 Sep 2008

References

  • Thompson D. F., Thompson G. D., Greenwood R. B., Trammel H. L. Therapeutic dosing of pralidoxime chloride. Drug Intell Clin Pharm 1987; 21: 590–593
  • Aaron C. K., Howland M. A. Insecticides: Organophos‐phates and carbamates. Goldfranks Toxicologic Emergencies5th Ed., L. R. Goldfrank, N. E. Flomenbaum, N. A. Lewin, et al. Appleton and Lange, Norwalk, CT 1994; 1105–1119
  • Litovitz T. L., Clark L. R., Soloway R. A. 1993 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1994; 12: 546–584
  • Sundwall A. Minimum concentrations of n‐methyl‐pyridinium‐2‐aldoxime methane sulphonate (PS2) which reverse neuromuscular block. Biochem Pharmacol 1961; 8: 413–417
  • Crook J. W., Goodman A. I., Colbourn J. L., Zvirblis P., Oberst F. W., Wills J. H. Adjunctive value of oral prophylaxis with the oximes 2‐PAM lactate and 2‐PAM methylsulfonate to therapeutic administration of atropine in dogs poisoned by inhaled sarin vapor. J Pharmacol Exp Ther 1962; 136: 397–399
  • Zvirblis P., Kondritiar A. A. Prophylaxis against sarin poisoning in the rat by oral administration of pralidoxime chloride. J Pharmacol Exp Ther 1967; 157: 432–434
  • Holmes R., Robins E. L. The reversal by oximes of neuromuscular block produced by anticholinesterase. Brit J Pharmacol Chemother 1955; 10: 490–495
  • Sidell F. R., Groff W. A. Intramuscular and intravenous administration of small doses of 2‐pyridinium aldoxime methochloride to man. J Pharm Sci 1971; 60: 1224–1228
  • Josselson J., Sidell F. R. Effect of intravenous thiamine on pralidoxime kinetics. Clin Pharmacol Ther 1978; 24: 95–100
  • Scott R. J. Repeated asystole following PAM in organophosphate self‐poisoning. Anesth Intensive Care 1986; 14: 458–460
  • Monograph on Pralidoxime. Physicians Desk Reference 1995; 49: 2735–2736
  • Stokoplsa M. J. Calculation of doses. Pharmaceutical Calculations7th Ed., M. J. Stokolsa, H. C. Ansel. Lea and Feibiger, Philadelphia 1990; 104
  • Benschop H. P., Konings K. A., Kossen S. P., Ligtenstein D. A. Determination of some pyridinium aldoxime compounds by means of ion‐pair reversed‐phased high‐performance liquid chromatography: application in biological material. J Chromatogr 1981; 225: 107–114
  • Farrar H. C., Wells T. G., Kearns G. L. Use of continuous infusion of pralidoxime for treatment of organophosphate poisoning in children. J Pediatr 1990; 116: 658–661
  • De Bleecker J., Willems J., Van Den Neucker K., De Reuck J., Vogelaers D. Prolonged toxicity with intermediate syndrome after combined parathion and methyl parathion poisoning. J Toxicol Clin Toxicol 1992; 30: 333–345
  • Willems J. L., Langenberg J. P., Verstraete A. G., et al. Plasma concentrations of pralidoxime methylsulfate in organophosphorus poisoned patients. Arch Toxicol 1992; 66: 260–266

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.